In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...
Ampatzis’s team mapped the exact composition, organization, and function of neurons in the IcNS using zebrafish as an animal ...
An ENT trainee shared her experience of juggling a medical career with motherhood, exposing the systemic biases faced by ...
Public health initiatives and physical education policies could incorporate ways to support movement among gender-diverse ...
Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...
SAN DIEGO — The multiple myeloma (MM) drug daratumumab (Darzalex), an anti-CD38 monoclonal antibody, dramatically reduced ...
New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...
Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...
Both radiotherapy and endocrine therapy are good single-modality options for women 70 years or older with early, favorable ...
Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive ...
Patients with low-risk DCIS were randomized to receive either guideline-concordant care or active monitoring and surveyed ...
Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback